GlassScriptPhysician profile
Zain Sobani
NPI 1275975351
$4,006.31
in general payments reported to CMS, 2019-2025
21 companies · $814 in 2025
The $814 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,200 · 2020: $282 · 2021: $187 · 2022: $336 · 2024: $188 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,384.93 | 2019-2025 | Resolution 360 Clip |
| Gilead Sciences, INC. | $461.83 | 2019-2020 | |
| Medtronic, INC. | $455.45 | 2022-2025 | Nexpowder, Gi Genius |
| Abbvie INC. | $363.08 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $197.69 | 2025 | |
| Conmed Corporation | $164.45 | 2025 | Conmed Biliary |
| Lucid Diagnostics INC. | $122.85 | 2022 | |
| Gi Supply, INC. | $119.38 | 2021 | |
| Madrigal Pharmaceuticals | $104.90 | 2025 | Rezdiffra |
| Covidien LP | $100.29 | 2020 | |
| Pfizer INC. | $94.33 | 2019 | |
| Lumendi LLC | $92.73 | 2021-2022 | |
| Endogastric Solutions, INC | $90.16 | 2022 | |
| Exelixis INC. | $43.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.76 | 2025 | Eohilia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $38.87 | 2019 | |
| Janssen Biotech, INC. | $37.99 | 2025 | Tremfya |
| Ardelyx, INC. | $26.84 | 2025 | Ibsrela |
| Mallinckrodt Hospital Products INC. | $26.09 | 2025 | Terlivaz |
| Aimmune Therapeutics, INC. | $19.69 | 2025 | Vowst |
| Shire North American Group INC | $19.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zain Sobani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.